Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



A study of A2B subgroup frequency among AB blood group in our tertiary care center

Neelaba K Mori, Chandrika Algotar, Siddharths Ghelani, Maitri Patel.




Abstract

Background: The ABO blood group system invented by Karl Landstiner is popular blood grouping system and considered as the most vitalin blood transfusion safety. Approximately, 20% of individuals having A2 subgroup and 80% have A1 subgroup.

Aims and Objectives: The objective of the present study is to find the prevalence of A1B and A2B subgroups in samples of patients in blood center of our tertiary care center.

Materials and Methods: This observational study was carried out at blood center of tertiary care hospital. Blood group is separated into A, B, AB, and O-positive/negative. Based on serological reactivity, blood group was classified into A2B positive/A2B negative.

Results: ABO blood grouping was analyzed for 5435 samples. Of these, 430 (7.91%) belonged to Group AB. Out of 430 AB group, 13 (3.1%) were having A2B-positive blood group and 417 (96.9%) were having A1B-positive blood group.

Conclusion: Among AB blood group, frequency of A1B subgroup is higher than A2B. The study of this subgrouping can make blood transfusion more safe and can improve overall practice of transfusion.

Key words: A2B Subgroup; Blood Bank; Blood Transfusion; Serological Reaction






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.